Prestwick3_000495

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers, 6 USDMF, 1 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

11 Dossiers, 10 FDA Orange Book, 1 Canada

DRUG PRODUCT COMPOSITION

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

Suppliers, 8 BASF, 7 Seppic, 4 Gangwal Chemicals, 3 Nanjing Well Pharmaceutical, 2 Actylis, 1 Jai Radhe Sales, 1 Nanjing Bold Chemical, 1 Finar

EXCIPIENTS BY APPLICATIONS

15 Solubilizers, 11 Topical, 6 Parenteral, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 3 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 1 Finished Drug Prices

MARKET PLACE

6 APIs

6 APIs

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

Pharmacy pricing data of Prestwick3_000495 obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Prestwick3_000495

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers

6 USDMF

1 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

11 Dossiers

10 FDA Orange Book

1 Canada

DRUG PRODUCT COMPOSITION

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

Suppliers

8 BASF

7 Seppic

4 Gangwal Chemicals

3 Nanjing Well Pharmaceutical

2 Actylis

1 Jai Radhe Sales

1 Nanjing Bold Chemical

1 Finar

EXCIPIENTS BY APPLICATIONS

15 Solubilizers

11 Topical

6 Parenteral

4 Emulsifying Agents

3 Surfactant & Foaming Agents

3 Thickeners and Stabilizers

3 Film Formers & Plasticizers

2 Direct Compression

1 Fillers, Diluents & Binders

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

1 Finished Drug Prices

MARKET PLACE

6 APIs

ANALYTICAL SOLUTION(s)

2 EDQM Standards

1 USP Standards

1 Other Ref. Standards

Prestwick3_000495

PADAGIS ISRAEL

Terconazole

TERCONAZOLE

SUPPOSITORY;VAGINAL

80MG

24.4110

RX

2006-03-17

USA

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons